The combination of sorafenib plus GdCl3 may significantly hepatic fibrosis by inhibiting angiogenesis, proinflammatory cytokines, and the interactions of HSCs, SECs and KCs. The gene discussed is TBCE; the disease is Hepatic fibrosis.